Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice

Journal of Experimental Medicine

Volumn 185, Issue 4, 1997, Pages 583-599

  Pearson, C I ^a   Van Ewijk, W ^b   McDevitt, H O ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD69 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; MYELIN BASIC PROTEIN; PADGEM PROTEIN; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNOTHERAPY; LEUKOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CD4-CD8 RATIO; CELL DIFFERENTIATION; CELL DIVISION; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; TH2 CELLS; THYMUS GLAND;

EID: 0031038173     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.4.583     Document Type: Article

References (61)

1. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458-466.
2. Fitch, F.W., M.D. McKisic, D.W. Lancki, and T.F. Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29-18.
3. Sher, A., and R.L. Goffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
4. Liblau, R.S., S.M. Singer, and H.O. McDevitt. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:34-38.
5. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
6. Samson, M.F., and D.E. Smilek. 1995. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155:2737-2746.
7. Metzler, B., and D.C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1159-1165.
8. Gaur, A., H. Wiers, A. Liu, J. Rothbard, and C.G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science (Wash. DC). 258:1491-1494.
9. Critchfield, J.M., M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Rainse, J. Goverman, and M. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (Wash. DC). 263:1139-1143.
10. Wraith, D.C., D.E. Smilek, D.J. Mitchell, L. Steinman, and H.O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:247-255.
11. u, which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 2:181-188.
12. Fairchild, P.J., R. Wildgoose, E. Atherton, S. Webb, and D.C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151-1158.
13. Karin, N., D.J. Mitchell, S. Brocke, N. Ling, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production. J. Exp. Med. 180:2227-2237.
14. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (Lond.). 379: 343-346.
15. Liblau, R.S., R. Tisch, K. Shokat, X.-D. Yang, N. Dumont, C.C. Goodnow, and H.O. McDevitt. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc. Natl. Acad. Sci. USA. 93:3031-3036.
16. Kearney, E.R., K.A. Pape, D.Y. Loh, and M.K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
17. Webb, S.R., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
18. De Wit, D., M. Van Mechelen, M. Ryelandt, A.C. Figueiredo, D. Abramowicz, M. Goldman, H. Bazin, J. Urbain, and O. Leo. 1992. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175:9-14.
19. Van Mechelen, M., D. De Wit, M. Ryelandt, S. Hjulstrom, M. Heynderickx, H. Bazin, J. Urbain, and O. Leo. 1995. Induction of Th2 responses to soluble proteins is independent of B cell tolerance status. Int. Immunol. 7:199-205.
20. Burstein, H.J., and A.K. Abbas. 1993. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 177:457-463.
21. Peterson, J.D., W.J. Karpus, R.J. Clatch, and S.D. Miller. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:46-55.
22. Liblau, R.S., C.I. Pearson, K. Shokat, R. Tisch, X.-D. Yang, and H.O. McDevitt. 1994. High-dose soluble antigen: peripheral T-cell proliferation or apoptosis. Immunol. Rev. 142: 193-208.
23. Patten, P.A., E.P. Rock, T. Sonoda, B. Fazekas de St. Groth, J.L. Jorgensen, and M.M. Davis. 1993. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J. Immunol. 150:2281-2294.
24. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (Lond.). 362:245-248.
26. Kappler, J.W., U. Staerz, J. White, and P.C. Marrack. 1989. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (Lond.). 332:35-40.
27. k monoclonal antibodies. J. Immunol. 128:751-757.
28. Hayakawa, K., H.H. Hardy, D.R. Parks, and L.A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med. 157:202-218.
29. Sander, B., I. Hoiden, U. Andersson, E. Moller, and J. Abrams. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and sera. J. Immunol. Methods. 166:201-214.
30. Larsen, C.P., S.C. Ritchie, R. Hendrix, P.S. Linsley, K.S. Hathcock, R.J. Hodes, R.P. Lowry, and T.C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208-5219.
31. Oi, V.T., P.P. Jones, J.W. Goding, L.A. Herzenberg, and L.A. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes. H-2 and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115-120.
32. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
33. Van Ewijk, W., P. Kisielow, and H. Von Boehmer. 1990. Immunohistology of T cell differentiation in the thymus of H-Y-specific T cell receptor α/β transgenic mice. Eur. J. Immunol. 20:129-137.
34. 33a. Brabb, T., E.S. Huseby, T.M. Morgan, D.B. Sant' Angelo, J. Kirchner, A.G. Farr, and J. Goverman. 1997. Thymic stromal organization is regulated by the specificity of T cell receptor/MHC interaction. Eur. J. Immunol. In press.
35. Berg, L.J., B. Fazekas de St. Groth, A.M. Pullen, and M.M. Davis. 1989. Phenotypic differences between αβ versus β T-cell receptor transgenic mice undergoing negative selection. Nature (Lond.). 340:559-562.
36. Wikstrom, M., K. Scott, M. Cook, and B. Fazekas de St. Groth. 1995. Peripheral tolerance in T cell receptor transgenic mice. J. Cell. Biochem. 21A(Suppl.):109.
37. lo thymocytes in vivo. Science (Wash. DC). 250:1720-1723.
38. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:363-371.
39. Sytwu, H.-K., R.S. Liblau, and H.O. McDevitt. 1996. Effect of the lpr/lpr mutant Fas gene and tumor necrosis factor (TNF) on antigen induced programmed cell death in HNT-TCR transgenic mice. Immunity. 5:17-30.
40. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (Lond.). 377:348-351.
41. Nicholson, L.B., J.M. Greer, R.A. Sobel, M.B. Lees, and V.K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:397-405.
42. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowle, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
43. + T helper cell phenotype development in a T cell receptor-αβ-transJ genic model. J. Exp. Med. 182:1579-1584.
44. Bretscher, P.A., G. Wei, J.N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science (Wash. DC). 257:539-542.
45. Murray, J.S., C. Pfeiffer, J. Madn, and K. Bottomly. 1992. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22:559-565.
46. + T cells. J. Exp. Med. 182:1591-1596.
47. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
48. Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M. Bernstein, X.Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:523-532.
49. Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette, and E. Sercarz. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon γ by T cells. Proc. Natl. Acad. Sci. USA. 92:9510-9514.
50. Sloan-Lancaster, J., and P.M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103-109.
51. Nabavi, N., G.J. Freeman, A. Gault, D. Godfrey, L.M. Nadler, L.H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (Lond.). 360:266-268.
52. Lenschow, D.J., G.H. Su, L.A. Zuckerman, N. Nabavi, C.L. Jellis, G.S. Gray, J. Miller, and J.A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA. 90:11054-11058.
53. Day, M.J., A.G. Tse, M. Puldavec, S.J. Simmonds, and D.W. Mason. 1992. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats. J. Exp. Med. 175:655-659.
54. Hsieh, C.-S., S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-721.
55. Guler, M.L., J.D. Gorham, C.-S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science (Wash. DC). 271:984-987.
56. Scott, B., R. Liblau, S. Degerman, A.L. Marconi, A.J. Caton, H.O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:72-83.
57. + subsets in leishmaniasis. J. Cell. Biochem. 53:323-328.
58. Szabo, S.J., N.G. Jacobson, A.S. Dighe, U. Gubler, and K.M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2:665-675.
59. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
60. O'Garra, A., and K. Murphy. 1996. Role of cytokines in development ot Th1 and Th2 cells. Chem. Immunol. 63:1-13.
61. Ramsdell, F., M.S. Seaman, R.E. Miller, K.S. Picha, M.K. Kennedy, and D.H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545-1553.